Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXRA | P19793 | 9/20 | 0.56 |
| ▸ | RXRB | P28702 | 8/20 | 0.56 |
| ▸ | RXRG | P48443 | 7/20 | 0.56 |
| ▸ | HPGD | P15428 | 3/20 | 0.56 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.54 |
| ▸ | PTGER1 | P34995 | 1/20 | 0.50 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.50 |
| ▸ | PTGER3 | P43115 | 1/20 | 0.50 |
| ▸ | PTGER2 | P43116 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | PSMD14 | O00487 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | CRHBP | P24387 | 1/20 | 0.49 |
| ▸ | PPARG | P37231 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.49 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.49 |
| ▸ | NR4A2 | P43354 | 2/20 | 0.48 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tucaresol SCHEMBL29400654 | 1.00 | RXRA (0.56) | RXRARXRBRXRGHPGDFOLH1 | |
| SCHEMBL23383954 | 0.88 | MAOB (0.53) | RXRARXRBRXRGALDH1A1MAPT | |
| SCHEMBL2370214 | 0.87 | MAPT (0.57) | FOLH1PTGER1PTGER4PTGER3PTGER2 | |
| SCHEMBL6027574 | 0.86 | MRGPRX4 (0.60) | RXRARXRBHPGDFOLH1KMT2A | |
| SCHEMBL27565831 | 0.85 | PTGER1 (0.47) | RXRARXRBRXRGHPGDFOLH1 | |
| SCHEMBL24702757 | 0.85 | RAB9A (0.49) | RXRARXRBRXRGHPGDFOLH1 | |
| SCHEMBL5756261 | 0.85 | MAPT (0.61) | RXRAHPGDKDM4EALDH1A1MAPT | |
| SCHEMBL23383726 | 0.85 | POLB (0.54) | RXRARXRBRXRGHPGDFOLH1 | |
| SCHEMBL23383976 | 0.85 | RXRA (0.70) | RXRARXRBRXRGHPGDFOLH1 | |
| SCHEMBL21798467 | 0.85 | RXRA (0.70) | RXRARXRBRXRGHPGDFOLH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 172 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230255963-A1 | SUBSTITUTED BENZALDEHYDE COMPOUNDS AND METHODS FOR THEIR USE IN INCREASING TISSUE OXYGENATION | GLOBAL BLOOD THERAPEUTICS INC (US) | 2023-08-17 | — | — | US | claimed |
| US-20220125786-A1 | SUBSTITUTED BENZALDEHYDE COMPOUNDS AND METHODS FOR THEIR USE IN INCREASING TISSUE OXYGENATION | GLOBAL BLOOD THERAPEUTICS INC (US) | 2022-04-28 | — | — | US | claimed |
| US-20210290619-A1 | SUBSTITUTED BENZALDEHYDE COMPOUNDS AND METHODS FOR THEIR USE IN INCREASING TISSUE OXYGENATION | GLOBAL BLOOD THERAPEUTICS, INC. | 2021-09-23 | — | — | US | claimed |
| US-20180369281-A1 | METHOD OF AMELIORATING SIDE EFFECTS OF SICKLE CELL DISEASE TREATMENTS | ALBERT EINSTEIN COLLGE OF MEDICINE, INC. (US) | 2018-12-27 | — | — | US | claimed |
| WO-2017083281-A1 | METHOD OF AMELIORATING SIDE EFFECTS OF SICKLE CELL DISEASE TREATMENTS | ALBERT EINSTEIN COLLEGE OF MEDICINE, INC. (US) | 2017-05-18 | — | — | WO | claimed |
| US-20150344472-A1 | SUBSTITUTED BENZALDEHYDE COMPOUNDS AND METHODS FOR THEIR USE IN INCREASING TISSUE OXYGENATION | GLOBAL BLOOD THERAPEUTICS, INC. | 2015-12-03 | — | — | US | claimed |
| EP-2797416-A1 | SUBSTITUTED BENZALDEHYDE COMPOUNDS AND METHODS FOR THEIR USE IN INCREASING TISSUE OXYGENATION | Global Blood Therapeutics, Inc. (US) | 2014-11-05 | — | — | EP | claimed |
| US-20130190315-A1 | SUBSTITUTED BENZALDEHYDE COMPOUNDS AND METHODS FOR THEIR USE IN INCREASING TISSUE OXYGENATION | GLOBAL BLOOD THERAPEUTICS, INC. (US) | 2013-07-25 | — | — | US | claimed |
| WO-2013102142-A1 | SUBSTITUTED BENZALDEHYDE COMPOUNDS AND METHODS FOR THEIR USE IN INCREASING TISSUE OXYGENATION | GLOBAL BLOOD THERAPEUTICS, INC. (US) | 2013-07-04 | — | — | WO | claimed |
| EP-1107785-B1 | METHOD OF DNA VACCINATION | GLAXO GROUP LTD (GB) | 2008-10-15 | — | — | EP | claimed |
| US-5872151-A | ADMINISTERING TO AN IMMUNODEFICIENT PATIENT FOR TREATMENT OF VIRUS INFECTIONS AN IMMUNOPOTENTIATORY AMOUNT OF 4-(2-FORMYL-3-HYDROXYPHENOXYMETHYL)BENZOIC ACID OR SALTS | GLAXO WELLCOME INC. (US) | 1999-02-16 | — | — | US | claimed |
| EP-0609606-B1 | Tucaresol as an immunopotentiatory agent | WELLCOME FOUND (GB) | 1996-12-11 | — | — | EP | claimed |
| US-5508310-A | ADMINISTERING SUBSTITUTED ALDEHYDES OR KETONES WHICH CAN REACT WITH T-CELL SURFACE GROUPS TO FORM SCHIFF BASES | BURROUGHS WELLCOME CO. (US) | 1996-04-16 | — | — | US | claimed |
| EP-0678298-A2 | Use of 4-(2-formyl-3-hydroxyphenoxymethyl)benzoic acid as immopotentiatory agent | THE WELLCOME FOUNDATION LIMITED (GB) | 1995-10-25 | — | — | EP | claimed |
| EP-0614357-A1 | IMMUNOPOTENTIATORY AGENTS | THE WELLCOME FOUNDATION LIMITED (GB) | 1994-09-14 | — | — | EP | claimed |
| EP-0609606-A1 | Tucaresol as an immunopotentiatory agent | THE WELLCOME FOUNDATION LIMITED (GB) | 1994-08-10 | — | — | EP | claimed |
| WO-1994007479-A2 | IMMUNOPOTENTIATORY AGENTS | THE WELLCOME FOUNDATION LIMITED (GB) | 1994-04-14 | — | — | WO | claimed |
| EP-0054924-B1 | PHARMACEUTICAL COMPOUNDS, THEIR PREPARATION AND USE | THE WELLCOME FOUNDATION LIMITED (GB) | 1986-08-06 | — | — | EP | claimed |
| US-4535183-A | PALLIATION OF SICKLE CELL ANEMIA, RESPIRATORY DISORDERS, HYPOXIA, RADIOSENSITIZATION OF TUMORS | BURROUGHS WELLCOME CO. (US) | 1985-08-13 | — | — | US | claimed |
| EP-0054924-A2 | Pharmaceutical compounds, their preparation and use | THE WELLCOME FOUNDATION LIMITED (GB) | 1982-06-30 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150344472-A1 | SUBSTITUTED BENZALDEHYDE COMPOUNDS AND METHODS FOR THEIR USE IN INCREASING TISSUE OXYGENATION | HBB, HBG2, MB | RXRA 2016/4885RXRB 1425/4885RXRG 1766/4885 |
| US-20230255963-A1 | SUBSTITUTED BENZALDEHYDE COMPOUNDS AND METHODS FOR THEIR USE IN INCREASING TISSUE OXYGENATION | HBB, HBG2, MB | RXRA 2016/4885RXRB 1425/4885RXRG 1766/4885 |
| US-20220125786-A1 | SUBSTITUTED BENZALDEHYDE COMPOUNDS AND METHODS FOR THEIR USE IN INCREASING TISSUE OXYGENATION | HBB, HBG2, MB | RXRA 2016/4885RXRB 1425/4885RXRG 1766/4885 |
| US-20130190315-A1 | SUBSTITUTED BENZALDEHYDE COMPOUNDS AND METHODS FOR THEIR USE IN INCREASING TISSUE OXYGENATION | HBB, HBG2, MB | RXRA 2016/4885RXRB 1425/4885RXRG 1766/4885 |
| US-20180369281-A1 | METHOD OF AMELIORATING SIDE EFFECTS OF SICKLE CELL DISEASE TREATMENTS | HBG1, HBG2, HBB | RXRA 2317/4885RXRB 1942/4885RXRG 1979/4885 |
| US-20210290619-A1 | SUBSTITUTED BENZALDEHYDE COMPOUNDS AND METHODS FOR THEIR USE IN INCREASING TISSUE OXYGENATION | HBB, HBG2, MB | RXRA 2016/4885RXRB 1425/4885RXRG 1766/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.